Senti Biosciences HoldingsSNTI +3.00%22 Market Cap is $32.08 Mil as of Jul. 12, 2026. GuruFocus rates SNTI with a GF Score™ of 22/100. The stock has 7 warning signs investors should review. Among 1,423 Biotechnology companies, Senti Biosciences Holdings ranks worse than 70.13% on this metric.
Senti Biosciences Holdings's quarterly market cap
declined
from Sep. 2025 ($37.07 Mil) to Dec. 2025 ($32.11 Mil) and
declined
from Dec. 2025 ($32.11 Mil) to Mar. 2026 ($25.29 Mil).
Senti Biosciences Holdings's annual market cap
declined
from Dec. 2023 ($30.16 Mil) to Dec. 2024 ($16.95 Mil) but then
increased
from Dec. 2024 ($16.95 Mil) to Dec. 2025 ($32.11 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Senti Biosciences Holdings's Enterprise Value for Today is $42.29 Mil.
Senti Biosciences Holdings (NAS:SNTI) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Senti Biosciences Holdings Market Cap Related Terms
Senti Biosciences Holdings Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Senti Biosciences Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Senti Biosciences Holdings Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Senti Biosciences Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where Senti Biosciences Holdings's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Senti Biosciences Holdings (SNTI) has a Market Cap of $32.08 Mil as of Jul. 12, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Senti Biosciences Holdings and its competitors. According to the industry distribution chart, Senti Biosciences Holdings ranks #998 out of 1423 companies in the Biotechnology industry, placing it in the top 70.1%.
Is Senti Biosciences Holdings' Market Cap too high?
Senti Biosciences Holdings' current Market Cap is $32.08 Mil. The Biotechnology industry median Market Cap is 121.30. Senti Biosciences Holdings' value of $32.08 Mil is 73.6% below this industry median. Based on the distribution chart, Senti Biosciences Holdings ranks #998 out of 1423 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Senti Biosciences Holdings has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Senti Biosciences Holdings' Market Cap compare to ALGS and CRVO?
According to the Biotechnology industry distribution chart, Senti Biosciences Holdings ranks #998 out of 1423 companies for Market Cap. This places Senti Biosciences Holdings in the lower half of its industry. The industry median Market Cap is 121.30. Senti Biosciences Holdings' value of $32.08 Mil is 73.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 121.30, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Senti Biosciences Holdings's current Market Cap of $32.08 Mil is 73.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Senti Biosciences Holdings and its competitors. For the Biotechnology industry, the median Market Cap is 121.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Senti Biosciences Holdings's current Market Cap is $32.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Senti Biosciences Holdings stock overvalued right now?
Senti Biosciences Holdings (SNTI) has a current Market Cap of $32.08 Mil. The current Market Cap is $32.08 Mil and 73.6% below the Biotechnology industry median of 121.30. Senti Biosciences Holdings' overall GF Score™ is 22/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Senti Biosciences Holdings (SNTI), the current Market Cap is $32.08 Mil as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Senti Biosciences Holdings Inc, formerly known as Senti Biosciences Inc, is a clinical-stage biotechnology company developing cell and gene therapies using its gene circuit platform for patients with incurable diseases. Its gene circuits, created from proprietary DNA sequences, are designed to reprogram cells to sense, compute, and respond to cellular environments. Its product candidates are to kill cancer cells, spare healthy cells, increase specificity, and control drug expression. Its candidate, SENTI-202, is a logic-gated off-the-shelf CAR-NK cell therapy for blood cancers, currently in a Phase 1 clinical trial in the United States and Australia for relapsed or refractory hematological malignancies, including Acute Myeloid Leukemia (AML).
22GF Score
Get the complete analysis for SNTI
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SNTI has been successfully added to your 
